【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing incidences of chronic diseases
4.1.1.2 Technological advancements
4.1.1.3 Growing awareness levels
4.2 Market Restraint Analysis
4.2.1.1 High cost of therapeutic mAbs
4.3 Penetration & growth prospect mapping
4.4 Monoclonal Antibodies – SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Source Type Estimates & Trend Analysis
5.1 Monoclonal antibodies market: Source type movement analysis
5.2 Murine
5.2.1 Murine market, 2013 – 2024 (USD Billion)
5.3 Chimeric
5.3.1 Chimeric market, 2013 – 2024 (USD Billion)
5.4 Humanized
5.4.1 Humanized market, 2013 – 2024 (USD Billion)
5.5 Human
5.5.1.1 Human market, 2013 – 2024 (USD Billion)
Chapter 6 Market Categorization 2: Production Type Estimates & Trend Analysis
6.1 Monoclonal antibodies market: Production type movement analysis
6.2 In vitro
6.2.1 In vitro market, 2013 – 2024 (USD Billion)
6.3 In vivo
6.3.1 In vivo market, 2013 – 2024 (USD Billion)
Chapter 7 Market Categorization 3: Indication Estimates & Trend Analysis
7.1 Monoclonal antibodies market: Disease movement analysis
7.2 Cancer
7.2.1 Cancer Market, 2013 – 2024 (USD Billion)
7.3 Autoimmune diseases
7.3.1 Autoimmune diseases market, 2013 – 2024 (USD Billion)
7.4 Inflammatory diseases
7.4.1 Inflammatory diseases market, 2013 – 2024 (USD Billion)
7.5 Infectious diseases
7.5.1 Infectious diseases market, 2013 – 2024 (USD Billion)
7.6 Microbial diseases
7.6.1 Microbial diseases market, 2013 – 2024 (USD Billion)
7.7 Others
7.7.1 Others diseases market, 2013 – 2024 (USD Billion)
Chapter 8 Market Categorization 4: End-Use Estimates & Trend Analysis
8.1 Monoclonal antibodies market: End-use movement analysis
8.2 Hospitals
8.2.1 Hospitals market, 2013 – 2024 (USD Billion)
8.3 Research Institutes
8.3.1 Research institutes market, 2013 – 2024 (USD Billion)
8.4 Others
8.4.1 Others market, 2013 – 2024 (USD Billion)
Chapter 9 Market Categorization 5: Regional Estimates & Trend Analysis, by Source Type, Production Type, Indication & End-Use
9.1 Monoclonal antibodies market shares by region, 2015 & 2024
9.2 North America
9.2.1 North America Monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.2 U.S.
9.2.2.1 U.S. monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.3 Canada
9.2.3.1 Canada monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3 Europe
9.3.1.1 Europe monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.2 Germany
9.3.2.1 Germany monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.3 UK
9.3.3.1 UK monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4 Asia Pacific
9.4.1.1 Asia Pacific monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.2 Japan
9.4.2.1 Japan monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.3 China
9.4.3.1 China monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.4 India
9.4.4.1 India monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5 Latin America
9.5.1.1 Latin America monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.2 Brazil
9.5.2.1 Brazil monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.3 Mexico
9.5.3.1 Mexico monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6 MEA
9.6.1.1 MEA monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6.2 South Africa
9.6.2.1 South Africa Monoclonal antibodies market estimates and forecasts, 2013 – 2024
Chapter 10 Competitive Landscape
10.1 Strategy framework
10.2 Market participation categorization
10.3 Company Profiles
10.3.1 Novartis International
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 Pfizer
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 GlaxoSmithKline Plc
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 Amgen Inc.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 Merck & Co., Inc.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 Daiichi Sankyo
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 Abbott Laboratories
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 AstraZeneca plc
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 Eli Lilly
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 Johnson & Johnson
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 Bayer AG
10.3.11.1 Company Overview
10.3.11.2 Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.4 Strategic Initiatives
10.3.12 Bristol Myers Squibb
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.4 Strategic Initiatives
10.3.13 F.Hoffman-La Roche Ltd.
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 Mylan N.V.
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives
10.3.15 Biogen Idec Inc.
10.3.15.1 Company Overview
10.3.15.2 Financial Performance
10.3.15.3 Product Benchmarking
10.3.15.4 Strategic Initiatives
10.3.16 Thermo Fisher Scientific
10.3.16.1 Company Overview
10.3.16.2 Financial Performance
10.3.16.3 Product Benchmarking
10.3.16.4 Strategic Initiatives
10.3.17 Novo Nordisk
10.3.17.1 Company Overview
10.3.17.2 Financial Performance
10.3.17.3 Product Benchmarking
10.3.17.4 Strategic Initiatives
10.3.18 Sanofi
10.3.18.1 Company Overview
10.3.18.2 Financial Performance
10.3.18.3 Product Benchmarking
10.3.18.4 Strategic Initiatives
10.3.19 Genzyme
10.3.19.1 Company Overview
10.3.19.2 Financial Performance
10.3.19.3 Product Benchmarking
10.3.19.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：モノクローナル抗体（mAb）の世界市場分析：由来別（キメラ、マウス、ヒト化、ヒト）、生産タイプ別、指示別（がん、自己免疫性、炎症性、感染性、微生物性、ウイルス性疾患）、エンドユーザー別（病院、研究機関、学術機関、診療所、診断研究所）、セグメント予測、2013 – 2024■ 英文：Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use (Hospitals, Research, Academic Institutes, Clinics, Diagnostic Laboratories) And Segment Forecasts, 2013 - 2024
■ 発行日：2016年11月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707560
■ 調査対象地域：グローバル
- 鼻ポリープ（Nasal Polyps）：グローバル臨床試験レビュー（2014年上半期）Nasal Polyps Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Nasal Polyps Global Clinical Trials Review, H1, 2014" provides data on the Nasal Polyps clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasal Polyps. It includes an overview of the trial numbers and their recruitment status as per the sit …
- 指向性エネルギー兵器（DEW）の世界市場This report studies the directed energy weapons market during the forecast period of 2015 to 2020. The market size is projected to reach USD 24.3 billion by the end of 2020, at a CAGR of 23.96% from 2015 to 2020. North America is estimated to hold the largest share of the directed energy weapons market, followed by Europe. In the Middle East, this market is projected to grow at the highest CAGR of …
- パイプライン安全の世界市場：技術、ソリューション、サービス、産業、地域MarketsandMarkets forecasts the pipeline safety market size to grow from USD 5.57 Billion in 2016 to USD 8.67 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 9.3%. Need for sustainable use of resources and increased spending by oil & gas companies for infrastructure and network protection are some of the key factors driving the market. The other driving forces include the expansion and …
- テクニカルテキスタイルの世界市場予測Technical textiles is a global knowledge-based research-oriented industry. Since the past few years, the sector is gaining slow but steady growth worldwide due to its technical performance and functional properties in the global textiles industry. Technical textile is a special type of material or product designed for specific applications, while offering unique & exclusive characteristics that ar …
- マイクロファイナンスの世界市場2016-2020About Microfinance Microfinancing is a type of banking service that is provided to low-income individuals or the unemployed or groups of people that do not have any means to obtain any financial services. The goal of microfinance companies is to provide an opportunity for low-income borrowers to become self-sufficient through saving and borrowing money and providing microinsurance. Microfinance in …
- スマートスピーカーの世界市場2019-2023Global Smart Speaker Market: About this market Smart speakers are internet-enabled that are controlled by voice commands. Technavio’s smart speaker market analysis considers sales to residential users and commercial users' segments. Our analysis also considers the sales of smart speaker in APAC, Europe, MEA, North America, and South America. In 2018, the residential users segment held the highest …
- 世界の帯域幅市場調査サービス（年間購読）TeleGeography’s Global Bandwidth Research Service is the world’s most comprehensive and authoritative source of data and analysis for long-haul networks and the undersea cable market.
- マンガンの世界市場動向2014/2015The report presents a thorough study of manganese, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing manganese worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: manganese production in the country, major manu …
- 筋萎縮性側索硬化症（Amyotrophic Lateral Sclerosis）：グローバル臨床試験動向（2014年上半期）Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2014" provides data on the Amyotrophic Lateral Sclerosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Amyotrophic Lateral Sclerosis. It includes an overv …
- エピネフリン・オートインジェクターの世界市場2015-2019About Epinephrine Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the …
- ムコ多糖症II型(MPS II)(ハンター症候群)(Mucopolysaccharidosis II (Hunter Syndrome))：治療薬開発パイプライン動向（2015年上半期版）Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mucopolysaccharidosi …
- 世界のロジスティクス市場：エンドユーザー別、地域別Global Logistics Market: About this market Technavio’s logistics market analysis considers sales from consumer goods, automotive, food and beverage, healthcare, and other end-users. Our study also finds the sales of logistics in APAC, Europe, MEA, North America, and South America. In 2019, the consumer goods segment had a significant market share, and this trend is expected to continue over the fo …
- 下着の世界市場2015-2019About intimate apparel Intimate apparel is considered as the second skin of consumers, as it is the second layer of all other clothes. The success of the global intimate apparel market lies in understanding the right trend, deciding the appropriate time of launch, and selecting the right distribution store. Specialist lingerie retailers should keep in mind the price band and the average sales cycl …
- CMV：医療検査市場2014The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- ホットランナーの世界市場：バルブゲートホットランナー、オープンゲートホットランナーThe global hot runner market size was $2,854.0 million in 2018, and is expected to reach $5,241.5 million by 2026, growing at a CAGR of 7.9% from 2019 to 2026. A hot runner system includes a compilation of heated components that include nozzles, hot valves, and gates that convey plastic polymer into the cavities of an injection mold. The system typically contains numerous heated nozzles and a heat …
